Lotus Sees Strong Demand and an Undersupply of High-Quality Product in the Market

As recently reported by the Ontario Cannabis Store, during the April 1, 2020 to June 30, 2020 period, cannabis flower with a THC% greater than 20% sold 101x and 161x more on the Ontario Cannabis Store website and in retail stores, respectively.

During the June to October period, Lotus’ cannabis flower averaged a THC% of approximately 25% and the Company saw an increased demand for its product nationally on a wholesale basis. The Company’s internal research also indicates a 1.2% market share of total sales in the Ontario flower market since its collaborative strain launch with Kolab Project. With our low cost of production and the strong demand for a premium product, Lotus has the opportunity and the reason to expand production further in a market that has lagged on the need for product quality. 
To learn more about Lotus, download our most recent investor presentation here.ON BEHALF OF THE BOARD:Lotus Ventures Inc.”Dale McClanaghan”Dale McClanaghan, President and CEOAbout Lotus Ventures Inc.     Lotus Ventures Inc. (CSE: J) is the publicly traded licensed producer that owns Lotus Cannabis Co., a premium-craft cannabis brand in Canada. Lotus grows rare and new-to-market strains of cannabis, while providing consistency and reliability through its innovative purpose-built facility that was created in BC’s North Okanagan region. The facility was designed for the ideal growing conditions that cannabis plants need to thrive in, using a high-performance harvest schedule with fresh biweekly harvests. Lotus has decades of growing experience and uses an entirely handcrafted production process created by one of the region’s most knowledgeable growing teams.  To learn more, visit https://lotuscannabis.ca/ or follow us on Twitter: @lotuscannabisco Facebook: @lotuscanna Instagram: @lotuscannabisco LinkedIn: @lotuscannabiscoForward Looking Information:The information contained within this news release has been prepared by Lotus Ventures Inc. This document includes certain statements that are not descriptions of historical facts but are forward-looking statements. Such statements include, among others, those concerning our expected financial performance and strategic and operational plans, our future operating results, our expectations regarding the market for medical and recreational cannabis products, our expectations regarding the continued growth of the medical and recreational cannabis market, as well as all assumptions, expectations, predictions, intentions or beliefs about future events. Users are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause our actual results to differ materially from those anticipated, expressed or implied in the forward-looking statements. These risks and uncertainties have not been documented or mentioned in this document nor other communications made by the company. The words “believe,” “expect,” “anticipate,” “project,” “targets,” “optimistic,” “intend,” “aim,” “will” or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.SOURCE Lotus Ventures Inc.For further information: President & CEO, Dale McClanaghan, [email protected], 604-644-9844; Investor Relations, Daniel McRobert, [email protected], 604-842-4625

By OCN Media News

OnlyCannabisNews scours the web and brings you the latest and most important cannabis related news across a variety of categories. OnlyCannabisNews focuses on reporting and promoting the stories of people and organizations in the world of cannabis.

Last Updated October 23, 2020

..
..
Related Stories
Instadose Pharma Corp and the Future of Medicinal Cannabis

Instadose Pharma Corp and the Future of Medicinal Cannabis

The hope is that these countries will benefit from the development of a global market for Medicinal Cannabis Tweet this Instadose Pharma Corp participated in a similar virtual conference held by Future Cannabis Strategies North America August 18, 2021 where they spoke...

Charlotte’s Web Launches Pet Chew for Dogs with Sensitive Skin

Charlotte’s Web Launches Pet Chew for Dogs with Sensitive Skin

Charlotte's Web™ Skin Health & Allergy Support Chews are chicken flavored and come in 30-count ($19.99 SRP) and 60-count ($34.99 SRP) sizes and are non-GMO and grain-free. Like all Charlotte's Web products, all pet SKUs are tested 20+ times from seed to shelf for...

OCN Exclusive content
Shantal Arroyo: Clinique La Croix Verte

Shantal Arroyo: Clinique La Croix Verte

Who: Shantal Arroyo Title: Co-founder Organization: Clinique La Croix Verte Facebook Page Corporate SitePour lire cet article en français, veuillez suivre ce lien.Introduction to Shantal Arroyo Shantal Arroyo is the founder of Clinique La Croix Verte, a medical...

Shantal Arroyo: Clinique La Croix Verte (français)

Shantal Arroyo: Clinique La Croix Verte (français)

Qui: Shantal Arroyo Titre: Co-fondatrice Organization: Clinique La Croix Verte Page Facebook Site CorporatifTo read this article in English, please follow this link.Présentation de Shantal Arroyo   Shantal Arroyo est la fondatrice de la Clinique La Croix Verte,...

James Williams: Cannabis Manufacturer’s Guild

James Williams: Cannabis Manufacturer’s Guild

Who: James Williams Title: Co-founder Company: Cannabis Manufacturer's Guild Company LinkedIn Profile Company WebsiteIntroduction to James Williams OnlyCannabisNews was given the opportunity to interview James Williams of the Cannabis Manufacturer's Guild. James...